SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...

SANTA CLARA, Calif., Feb. 20, 2018 /CNW/ -- Based on its recent analysis of the biologics downstream processing technologies industry, Frost & Sullivan recognizes 3M with the 2017 Global Product ...

Defense ministry says Taiwan prepared for Venezuela-style strike scenario Request To Download Free Sample of This Strategic Report @- Downstream processing involves the purification and recovery of ...

Ottawa, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The filtration in biologics market is set for significant growth from 2024 to 2034, fueled by rising global demand for monoclonal antibodies, vaccines, and ...

For decades, therapeutic monoclonal antibody (mAb) production relied on traditional batch-based manufacturing using stainless steel systems. But as biopharmaceutical pipelines grow to meet rising ...

SHANGHAI, Aug. 30, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has ...

Rapid process development and scale-up of novel complex drugs requires advanced PAT tools, capable of providing timely feedback on product attributes. Real-time multi-angle light scattering (RT-MALS) ...

Since the first monoclonal antibody (OKT3) was approved in 1986, the FDA has granted approval to more than 100 antibody-based therapeutic products, including monoclonal antibodies (mAbs), fusion ...

WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics development and manufacture. The platform can significantly ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--JSR Life Sciences, LLC today announced that its lead product, Amsphere™ A3, has been incorporated for the first time into the commercial manufacturing of an ...